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PhosphoSerine/Threonine Binding Minireview
Domains: You Can’t pSERious?
14-3-3 Proteins
The term “14-3-3” denotes a family of dimeric a-helical
pSer/Thr binding proteins present in high abundance in
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Over 50 distinct substrates have been identified thatSummary
bind to 14-3-3, many of which play critical roles in regu-
lating progression through the cell cycle, activation ofThe fundamental biological importance of protein phos-
phorylation is underlined by the existence of more than the Erk1/2 subfamily of MAP kinases, initiation of apo-
ptosis, and control of gene transcription and chromo-500 protein kinase genes within the human genome. In
many cases, phosphorylation on serine, threonine, and some remodeling. Both the maintenance of cells in in-
terphase [4], for example, and the G2/M cell cycle arresttyrosine residues creates binding surfaces for a variety
of phospho-amino acid binding proteins/modules. observed in rapidly dividing cells following DNA damage
[5] involve the binding of 14-3-3 proteins to a specificHere, we review the insights into serine/threonine phos-
phorylation-dependent signal transduction processes phosphorylated form of the mitotic regulatory tyrosine
phosphatase Cdc25. The resulting 14-3-3:Cdc25 com-provided by structures of several of these proteins and
their complexes. plex localizes to the cytoplasm [6–9], blocking Cdc25’s
access to its nuclear substrate, Cdc2-CyclinB, and
thereby regulating mitotic entry. The binding of 14-3-3Introduction
Signal transduction in eukaryotic cells involves the as- dimers to phosphorylated forms of A-Raf, B-Raf, and
c-Raf-1 plays a complex and incompletely understood rolesembly of various protein and lipid kinases and phos-
phatases along with other enzymes, adaptors, and regu- in Raf activation and MAP kinase signaling, probably
through a combination of stabilizing the active form oflatory molecules into large protein complexes. These
multicomponent signaling machines integrate and trans- Raf, facilitating the interaction of Raf with downstream
effectors, and maintaining inactive Raf in a reactivatablemit information to control ion fluxes, cytoskeletal re-
arrangements, patterns of gene expression, cell cycle conformation [10–12]. Several 14-3-3-regulated ligands
are physiological effectors of apoptosis, including phos-progression, and programmed cell death. The dynamic
nature of signaling events requires rapid assembly and phorylated forms of the kinase ASK1 [13], the Forkhead
transcription factor FKHRL1 [14], and the Bcl-2 familydisassembly of signaling complexes, events that are
generally regulated through protein phosphorylation. member BAD [15]. Other 14-3-3 binding molecules in-
clude several transcriptional activators and coactivatorsHistorically, attention has focused on the assembly of
multiprotein complexes that were regulated by tyrosine [16], human telomerase [17], and histone deacetylases
4 and 5 [18].phosphorylation of transmembrane receptors to gener-
ate binding sites for proteins with modular SH2 and PTB Through what feat of structural gymnastics do 14-3-3
proteins accomplish their phosphospecific recognitiondomains. In contrast, phosphorylation of proteins on
serine and threonine residues was thought to regulate while binding to such a diverse array of ligands? Some
insight into this dilemma has emerged through studiesprotein function largely through allosteric modifications
of 14-3-3:phosphopeptide complexes.rather than by directly mediating protein–protein inter-
Each monomer of the dimeric 14-3-3 molecule con-actions. Within the last few years, however, a variety of
tains nine a helices, with the individual monomeric sub-signaling molecules and modular domains have been
units related to each other by C2 symmetry [19, 20]identified that specifically bind to short pSer/Thr-con-
(Figure 1). The three N-terminal helices of each monomertaining motifs, recruiting these substrates into protein–
interact extensively with those of the opposing mono-protein signaling complexes in response to phosphory-
mer through a combination of salt bridges, hydrogenlation by Ser/Thr kinases. In this review, we focus on the
bonds, and van der Waals interactions, forming a 35 3identification of these new pSer/Thr binding modules,
35 3 20 A˚ wide central channel suitable for binding toincluding 14-3-3 proteins, WW domains, and FHA do-
peptide and protein ligands. The residues lining thismains; their physiological functions and the structural
central channel show extensive sequence conservationbasis for their pSer/Thr motif recognition.
among all seven 14-3-3 isotypes found in mammalian
cells [19]. Three basic residues, Lys49, Arg56, and‡ To whom correspondence should be addressed (e-mail: myaffe@
mit.edu, ssmerdo@nimr.mrc.ac.uk). Arg127, together with Tyr128, emerge from helices C
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phosphates is not unique to the all-helical 14-3-3 pro-
teins. The b sheet–based SH2 and PTB domains bind
to all or part of their tyrosine-phosphorylated ligands in
an extended conformation and use a similar pattern
of basic and hydroxyl-containing side chains to form
multiple ionic and hydrogen bonds with the phosphoty-
rosine phosphate. Two Arg residues in SH2 domains
make important contributions: there is a bidentate ionic
interaction between two of the guanidino nitrogens in
a buried Arg residue, bB5, and two of the phosphate
oxygens and a combined salt bridge and amino-aro-
matic interaction between guanidino nitrogens in Arg
aA2 and the Tyr phosphate and ring system, respectively
[21, 22]. In addition, there are interactions involving the
amino side chain of Lys bD6, the hydroxyl of Ser bB7,
the main chain NH of Glu BC1, and the hydroxyl of Thr/
Ser BC2 in the Src and Lck SH2 domain structures [22,
23]. Likewise, in the Shc PTB domain, the phosphotyro-
sine interaction involves two Arg residues (Arg175 and
Arg67), the amino group on a Lys side chain (Lys169),
and the hydroxyl side chain of Ser151 [24]. Thus, it would
appear that 14-3-3 proteins, most SH2 domains, and a
number of PTB domains have independently evolved a
similar arrangement of amino acid side chains for high-
affinity phospho-amino acid binding.
WW DomainsFigure 1. 14-3-3 Proteins Bind Phosphoserine Peptides within a
WW domains constitute one of the smallest modulesLarge Central Channel
found widely distributed in signaling proteins, often inEach monomeric subunit of the dimer, shaded blue and red, respec-
association with HECT family ubiqitin ligase domains,tively, is composed of nine a helices (aA–aI), with each monomer
simultaneously binding a phosphopeptide. A single protein ligand, proline isomerase domains, PTB domains, and PDZ do-
when phosphorylated on two sites, probably binds in a similar man- mains. Comprised of z40 amino acids folded into three
ner to both monomers of the 14-3-3 dimer. Alternatively, two pro- antiparallel b strands, WW domains bind to short pro-
teins with single phosphorylation sites may bind to each monomer line-rich sequences containing PPXY, PPLP, or PPR
individually, allowing 14-3-3 to function as a molecular adaptor. The
motifs [25, 26] (Figure 2). Two proteins, the proline isom-phosphoserine phosphate is coordinated by a basic pocket formed
erase Pin1/Ess1 and the ubiquitin ligase Nedd4/Rsp5p,from the indicated residues emerging from two of the a helices
(bottom). A loosely similar arrangement of basic and hydroxyl-con- however, contain WW domains that can specifically rec-
taining side chains coordinates the peptide phosphotyrosine phos- ognize pSer-Pro and pThr-Pro motifs [27]. Intriguingly,
phate in SH2 and some PTB domain complexes. the proline isomerase domain of Pin1 catalyzes the spe-
cific cis-trans isomerization of pSer/Thr-Pro bonds, in
contrast to the conventional proline isomerases in the
and E to form a positively charged pocket located to- FKBP and cyclophilin families [28]. Since many Pin1
ward one end of each edge of the central channel in substrates are mitotic phosphoproteins, the conforma-
what is otherwise a largely negatively charged molecule. tional changes induced upon proline isomerization have
Each of the residues in this basic pocket interacts di- been proposed to regulate mitotic entry and exit. For
rectly with the peptide phosphate group, forming five two of Pin1’s phosphorylated substrates, Cdc25C and
ionic bonds and a hydrogen bond to three of the phos- Tau, proline isomerization facilitates their subsequent
phate oxygens (Figure 1) [2, 3]. This strong network of dephosphorylation by the Ser/Thr phosphatase PP2A
interactions, like the fingers of a hand balancing a [29], an event which requires the pSer-Pro bond to be
squash ball, forms the critical anchor that orients the in trans. Curiously, the Pin1 WW domain only binds to
remainder of the peptide, arguing for the importance of pSer-Pro peptides in the trans conformation [30], sug-
ligand phosphorylation in high-affinity 14-3-3 binding. gesting that one function of the WW domain may be
The phosphopeptide main chain is stabilized in an ex- to stabilize the trans-isomerase product in preparation
tended conformation by a series of hydrogen bonds for dephosphorylation. The Saccharomyces cerevisiae
between the peptide backbone NH and CO groups with Pin1 homolog, Ess1, regulates transcription and mitosis
the side chains of residues in helices E, G, and I. How- through binding the hyperphosphorylated C-terminal
ever, a sharp alteration in peptide chain direction occurs domain of RNA polymerase II in a region that contains
at a position that is two residues C-terminal to the pSer. 26–52 repeats of the motif YSPTSPS [31]. The struc-
Most physiological 14-3-3 binding proteins as well as ture of Pin1 complexed to the serine-phosphorylated
optimal 14-3-3 binding peptides contain a Pro residue YpSPTpSPS peptide has provided a structural basis for
at this position. The major effect of this kink is to redirect understanding the specificity displayed by some WW
the chain direction away from 14-3-3 and back into the domains toward phosphorylated ligands [30]. Overall,
central channel. the number of specific contacts between the ligand’s
phosphoserine phosphate and the WW domain’s sideThis type of four-fingered arrangement for “gripping”
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Figure 2. The Pin1 WW Domain Binds Phos-
phoserine-Proline Motifs
The left panel shows the two Trp residues,
for which these three-stranded b sheet struc-
tures are named, along with the trans confor-
mation of the pSer-Pro bonds in the bound
phosphopeptide from RNA polymerase II
(shaded purple). The right panel shows that
oxygen atoms from only one of the two pSer
phosphates interact directly with side chains
from residues in the b1/2 loop. This pattern
of phosphoserine coordination, together with
a water-mediated hydrogen bond from a Tyr
residue within b2, is less than that seen in 14-
3-3 and SH2 domain structures, consistent
with the finding that only a subset of WW
domains show phospho-specific binding.
chains was reduced compared to that seen in 14-3-3 ipate in phosphotyrosine signaling processes in higher
proteins (Figure 2). All of the phosphate contacts are eukaryotes.
made between the peptide’s second pSer and two resi- The in vivo binding partners for most FHA domain
dues in the b1–b2 loop (Ser16 and Arg17) along with proteins are unknown. Data regarding the specificity
one in the b2 strand (Tyr23). The Arg guanidino group of different FHA domains for phosphothreonine-based
participates in a bidentate interaction with two of the sequence motifs, however, emerged from peptide li-
phosphate oxygens along with a hydrogen bond from brary experiments [39]. FHA domains were found to rec-
the Arg17 main chain NH, while the Ser residue forms ognize short sequence motifs bracketing the central
a hydrogen bond with a third. Moreover, there is an phosphothreonine residue, with selection extending from
additional water-mediated hydrogen bond between Tyr23 the pT24 to the pT13 position. In many cases, the selec-
and one of the phosphate oxygens. Residues function- tion was strongest in the pT13 position, allowing a tenta-
ally equivalent to Ser16 and Arg17 are absent in the vast tive grouping of FHA domains into discrete classes on
majority of WW domains, suggesting that the pSer/pThr the basis of pT13 specificity. All FHA domains reported
binding function may be limited to a small subset of WW to date are pThr-specific, as pSer substitution eliminates
domains. peptide binding [39].
FHA Domains NMR analysis of the C-terminal FHA domain (FHA2)
Forkhead-associated (FHA) domains are found in a vari- from S. cerevisiae Rad53 revealed the overall fold and
ety of transcriptional control proteins, DNA damage– identified a likely interacting surface for phosphopeptide
activated protein kinases, cell cycle checkpoint pro- binding [37]. The high-resolution crystal structure of
teins, phosphatases, kinesin motors, and regulators of FHA1 from Rad53p in complex with a phosphothreo-
small G proteins in organisms ranging from mycobac- nine-containing peptide ligand (SLEVpTEADATFAKK)
teria and yeast to higher plants and humans. In humans, derived from Rad9p revealed the detailed architecture
many FHA domain–containing proteins appear to be of this class of signaling module and the unusual fea-
involved in processes protecting against cancer, since tures of phospho-dependent binding [39]. Both struc-
mutations in, or inactivation of, several FHA proteins, tures show the FHA domain to consist of an 11-stranded
including Chk2, p95/Nbs1, and Chfr, have been postu-
b sandwich that has an identical b strand topology to
lated to play a role in tumor formation. Originally identi-
the MH2 domains of Smad tumor suppressor molecules
fied as 55–75 amino acid modules by sequence profiling
(Figure 3). In both structures, the FHA homology region
[32], a variety of biophysical studies have now demon-
encompasses only six of the b strands that largely formstrated that FHA domains are considerably larger, en-
one side of the b sandwich. The N- and C-terminal bcompassing 130–140 amino acids. Several independent
strands lie adjacent to one another on the nonconservedlines of evidence led to the recognition that FHA do-
face of the domain. Indeed, the proximity of the N andmains were phosphothreonine binding modules, includ-
C termini is consistent with the modular nature of theing work showing that FHA domains played critical roles
FHA domain as an independently folded binding module.in the interaction between the protein phosphatase
The Rad53 FHA1:phosphopeptide complex revealsKAPP and phosphorylated receptor-like kinases in Ara-
that ligand binding occurs at one end of the molecule,bidopsis [33, 34] and between the cell cycle checkpoint
where it interacts with residues from the loops betweenkinase Rad53p and the phosphorylated DNA damage
b3/4, b4/5, and b6/7 (Figure 3). The conserved residuescontrol protein Rad9p in S. cerevesiae [35, 36]. Never-
within the FHA region either interact directly with thetheless, the work of Tsai and coworkers [37] has shown
peptide or form the structural framework upon whichthat Rad53 FHA2 is able to bind peptides containing
the peptide binding loops are presented. Of the six mostphosphotyrosine [37, 38]. Although the biological signifi-
highly conserved residues in the FHA family, three makecance of pTyr-dependent interactions in budding yeast
interactions with the peptide and, of these, Arg70 andremains to be demonstrated, these data indicate that
Ser85 bind directly to the pThr residue itself. Most ofFHA domains may constitute a rather promiscuous class
of phospho-dependent modules that may indeed partic- the phospho-independent contacts are formed between
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Figure 3. Structure of the Rad53 FHA1:Rad9
Phosphopeptide Complex
The fold topology of the FHA domain, an 11-
stranded b sandwich, and the phosphopep-
tide binding loops are indicated in the left
panel. Two critical Arg residues (green) inter-
act with the phosphothreonine phosphate
and the pT13 Asp residue in the Rad9 phos-
phopeptide (purple). Residues participating
in phosphothreonine phosphate coordination
are shown in the upper right panel. In addi-
tion, there is a pocket in the molecular surface
of the FHA domain that accepts the threonine
g-methyl group (lower right).
FHA domain side chains and main chain atoms of the oxygens of Asp13 form salt bridging interactions with
Ne and Nh atoms of Arg83 from the b4/5 loop. Intrigu-peptide. In this way, the peptide chain is held in an
extended conformation similar to that observed in SH2, ingly, the type of residue selected at this position varies
considerably in other FHA domains [39], but the basis14-3-3, and WW domain complexes. The phosphothreo-
nine side chain makes a total of five hydrogen bonds for selection at the 13 position in these cases awaits
further structural and biochemical analyses of FHA do-with main and side chain atoms from Thr106 and Asn86
and two of the highly conserved residues, Arg70 and main complexes.
WD40 and LRR Domains of F-Box ProteinsSer85. Arg70 forms the side of a basic pocket and makes
a charged hydrogen bond to the OG1 atom of the phos- Two other domains may function, in some circum-
stances, as pSer/Thr binding modules: the WD40 do-phothreonine The importance of this interaction is dem-
onstrated by mutagenesis of Arg70 to alanine, which mains and leucine-rich regions present within F-box pro-
teins.considerably lowers the binding affinity [39]. These ob-
servations are largely consistent with the recent NMR F-box proteins recognize substrates of SCF (Skp1-
Cdc53/Cullin-F-box) ubiquitin ligases, targeting them forstructure of Rad53 FHA2 in complex with a phosphotyro-
sine peptide [38], although in this case, the phosphate phosphorylation-dependent ubiquitination and protea-
somal degradation [41, 42]. In addition to the F-boxesmoiety appears to be somewhat displaced from the ob-
served position in the pThr complex, presumably due from which F-box proteins derive their names, most also
contain a WD40 or LRR (leucine-rich repeat) domainto differences in the size of the phosphorylated side
chain. that may be responsible for phosphosubstrate recogni-
tion. However, unlike 14-3-3, WW, and FHA domains,At present, the bulk of available biological and bio-
chemical data support the notions that in most cases, structural proof for direct binding of pSer/Thr peptides
to purified WD40 or LRR domains is lacking. LRR do-FHA domains function by specifically recognizing phos-
phorylated threonine residues in target proteins, and mains form multiple repeats of single a helix/b strand
units that align to form a large surface area for interactionsubstitution of pSer for pThr in model peptides abro-
gates or severely compromises binding. It appears that with substrates [43]. How such a structure might recog-
nize short pSer/Thr peptides is unclear. In contrast,the pThr rotamer observed in the Rad53 FHA1 is deter-
mined by steric clashes and by hydrogen bonding be- WD40 domains adopt a b propeller structure, which has
precedence for binding linear peptide motifs withintween the main chain N and a phosphate O. The threo-
nine g-methyl group sits in a cavity formed by side chain grooves formed by adjacent propeller blades [44].
Whether or not contributions from other componentsand main chains atoms from Ser85, the side chains of
Thr 106 and Asn 107, and backbone atoms encom- within the ubiquitination complex play important roles
in phosphospecific binding is currently unknown.passing Ser82–Ile84, forming extensive van der Waals
interactions that would not be possible with a pSer sub-
stitution (Figure 3). Concluding Remarks
The identification of several families of pSer/Thr bindingAs mentioned, many FHA domains show the strongest
amino acid discrimination in the pT13 position in ori- modules within the last four years presents new para-
digms for how cell signaling events can be regulated byented peptide screening experiments. In the case of
Rad53 FHA1, these methods select strongly for aspartic Ser/Thr phosphorylation. The remarkable diversity of
protein folds displayed by these domains, together withacid in the 13 position [39, 40]. Again, the X-ray structure
nicely explains this observation, since the carboxylate differences in how the ionized phosphate group is rec-
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